Healthcare Triangle, Inc. (HCTI): debt financing — Healthcare Triangle raises $6M via convertible notes with 20% OID; up to $15M total

Healthcare Triangle, Inc.

Initial tranche $7.5M principal (20% OID, net $6M) to institutional investors; matures Nov 20, 2026.
Notes convertible at greater of 80% of lowest 5-day VWAP or $0.38/share; 18% past-due interest rate.
Second $7.5M tranche conditioned on effective resale registration; registration must be filed within 10 days.
Stockholder approval needed for conversion shares >19.99% of outstanding; special meeting set for Nov 28, 2025.
Placement agent RBW Capital (Dawson James) receives 8% cash fee plus $100k in legal expenses.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Healthcare Triangle, Inc. incurred convertible notes of $7,500,000 with institutional investors at 18% per annum maturing November 20, 2026.

Instrument: convertible notes
Principal: $7,500,000
Counterparty: institutional investors
Rate: 18% per annum
Maturity: November 20, 2026
Event: incurrence

Exact text from the filing

Under the Purchase Agreement, the Company has agreed to issue 20% original issue discount senior unsecured convertible promissory notes (“Notes”) in an aggregate original principal amount of up to $15,000,000, which will be convertible into shares of the Company’s common stock, par value $0.00001 per share (“Common Stock”). The closing of the first tranche was consummated on November 20, 2025, and the Company issued the initial Note for an aggregate original principal amount of $7,500,000 (the “Initial Tranche”). The Note issued in the Initial Tranche was sold to the Investors for a purchase price of $6,000,000, representing an original issue discount of twenty percent (20%), and matures on November 20, 2026.

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Healthcare Triangle, Inc. issued convertible note to certain institutional investors for $6,000,000 purchase price for Initial Tranche principal amount of $7,500,000.

Security: convertible note
Purchaser: certain institutional investors
Consideration: $6,000,000 purchase price for Initial Tranche principal amount of $7,500,000

Exact text from the filing

(“Common Stock”). The closing of the first tranche was consummated on November 20, 2025, and the Company issued the initial Note for an aggregate original principal amount of $7,500,000 (the “Initial Tranche”). The Note issued in the Initial Tranche was sold to the Investors for a purchase price of $6,000,000, representing an original issue discount of twenty

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Healthcare Triangle, Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $6,000,000 (effective 2025-11-20).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional investors
Value: $6,000,000
Effective: 2025-11-20

Exact text from the filing

On November 20, 2025, Healthcare Triangle, Inc., a Delaware corporation, (the “Company”), entered into a Securities Purchase Agreement (“Purchase Agreement”) with certain institutional investors (the “Investors”).

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Healthcare Triangle, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-113672

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.